
    
      To evaluate the efficacy and safety of electroanatomic imaging (CARTO) compared to
      conventional fluoroscopically guided activation mapping (Conventional) method in patients
      with Atrial Fibrillation and Substrate-dependent Ventricular Tachycardia To evaluate
      cost-effectiveness of CARTO 3D image system compared to conventional method in the same study
      subjects
    
  